Thought Leadership for Life Science Leaders

Blog

Speak to Our Thought Leaders Today

“Refuse to Accept Policy for 510(k)s”: Critical FDA Guidance

Our very own Teresa Gorecki took to LinkedIn earlier this afternoon to announce…

A critical Guidance has been issued by FDA; the new Guidance, “Refuse to Accept Policy for 510(k)s”, is now available on fda.gov.

Refuse to Accept Policy for 510(k)s

This is an important Guidance document for all firms intending to file 510(k) s for products in their pipelines. Failure to meet these criteria will lead to a “refusal to accept” for the firm’s submission. This results in an increase in overall cycle time to final approval of new devices; once the submission is refused by FDA, the “time clock” begins again for all revised and resubmitted 510(k)s.

This slows approval of new devices; patients must wait for important new devices and technologies and firms must revise their launch calendars and financial projections accordingly. Patients are waiting. It is worth the effort to get the submission “ right the first time”. An overused “slogan” but now an FDA requirement for 510(k) submissions.

medical device Refuse to Accept Policy for 510(k)s

One industry expert was quick to reply, “Thanks for sharing – another example of how is raising the bar on

Contact Us

Fill out the form below to learn more about the FDA’s guidance on 510(k)s.

Advancing Clinical Investigator Site Audits: A Quality-Focused, Risk-Based Approach

Clinical research is undergoing a profound transformation, driven by technological innovation, globalization, evolving...

Learning from Recent FDA Warning Letters: A Call for Proactive Compliance

Every FDA Warning Letter offers more than a glimpse into individual noncompliance; it...

Informed consent is one of the most vital elements of ethical clinical research....